Introduction
The synthesis and secretion of adrenocorticotrophin (ACTH) from non-endocrine tumours may lead to the clinical picture of Cushing's syndrome. The condition is associated with ectopic lipotrophin secretion.' ACTH and lipotrophin are synthesised via a common precursor molecule,2 and the recently discovered opioid peptides 3-endorphin and methionine enkephalin share a common amino-acid sequence with the C-terminal portion of the 3-lipotrophin molecule. 3 We therefore decided to investigate the possibility of ectopic production of these peptides in patients with non-endocrine tumours secreting ACTH.
Patients and methods
We studied three women with the ectopic ACTH syndrome. The first patient (case 1), aged 39, presented in April 1973 with a manic psychosis and typical physical appearance of Cushing's syndrome. The diagnosis was confirmed biochemically, and over the next four years the disease took a cyclical course both clinically and biochemically and spontaneously remitted and recurred several times. In December 1977 a malignant thymic carcinoid tumour about 5 cm in diameter was discovered and removed. The second patient (case 2), aged 44, presented in January 1976 with depression and features of Cushing's syndrome, which was confirmed biochemically. A thymic carcinoid tumour 3 cm in diameter was discovered and removed in March 1979. The third patient (case 3), aged 37, presented in July 1979 with an 18-month history of Cushing's syndrome associated with depression. The diagnosis was confirmed biochemically, and in September a pulmonary carcinoid tumour 1 cm in diameter was removed from the left lower lobe. In all cases the psychiatric disturbances and Cushing's syndrome disappeared with removal of the tumours.
Tumour tissue obtained at operation was immediately frozen on dry ice and stored at -70°C until extraction and assay. The tissue was homogenised in 0 IM HC1 and after neutralisation was assayed in serial dilution for immunoreactive l-endorphin (C-terminal 3-lipotrophin)4 and methionine enkephalin.' The second assay is specific for methionine enkephalin, whereas the 3-endorphin assay shows complete molar cross-reactivity with 3-lipotrophin. Chromatography of fresh tumour extracts was performed on a 1-5 x 100 cm column of Sephadex G-75 equilibrated with 1 % formic acid containing 1 g Polypep (Sigma, P5115) and pumped upwards at 2 ml/h at 4°C, 1 8 ml fractions being collected. An aliquot of each fraction was then neutralised by dilution in assay buffer and assayed for 3-endorphin and methionine enkephalin. The column was calibrated with human 3-lipotrophin purified in this laboratory and with synthetic Pendorphin and methionine enkephalin (Bachem). This system of chromatography prevents 3-endorphin and methionine enkephalin being generated as artefacts from P-lipotrophin.' 6 Fresh control tissue obtained at operation from two patients without the ectopic ACTH syndrome was processed in the same manner as the tumours. Normal lung tissue was obtained from a patient with a pulmonary carcinoid tumour and thymic tissue from a patient with myasthenia gravis.
In case 2 blood samples taken simultaneously from a vein draining the tumour and from a peripheral vein were analysed for methionine enkephalin concentrations after extraction. ' 
Results
The 
Discussion
Ectopic 3-endorphin secretion was described in a patient with pancreatic islet-cell carcinoma.7 Our patients are the first reported cases in which methionine enkephalin has been found in non-endocrine tumours, and in all three this was associated with p-endorphin. These peptides were undetectable in normal lung tissue and thymic tissue from a patient with myasthenia gravis, suggesting that their presence in carcinoid tumours derived from these tissues was ectopic. That the methionine enkephalin concentration in blood from a vein draining the tumour was roughly twice that in a peripheral vein suggests that methionine enkephalin was secreted by this tumour. Enkephalin has been reported in an adrenal phaeochromocytoma and an adrenal ganglioneuroma,8 but these may not be classed as instances of ectopic enkephalin production as this peptide is normally found in the adrenal medulla. 9 Finding 3-endorphin and methionine enkephalin in nonendocrine tumours may have important clinical implications. These opioid peptides have profound behavioural effects on laboratory animals, including the -production of a catatonic-like state,'°11 and it is tempting to speculate that secretion of these peptides by the tumours could have been at least partly responsible for the psychiatric disturbances in our patients. Depressive illness may precede other clinical features of malignancy by several years,2 13 
